We are live on ! Find out more
LBA

Letko, Brosseau & Associates Portfolio holdings

AUM $6.77B
1-Year Est. Return 38.11%
This Fund
S&P 500
This Quarter Est. Return
-1.28%
1 Year Est. Return
+38.11%
3 Year Est. Return
+83.35%
5 Year Est. Return
+109.01%
10 Year Est. Return
+317.99%
AUM
$5.1B
AUM Growth
-$265M
Cap. Flow
-$139M
Cap. Flow %
-2.71%
Top 10 Hldgs %
33.26%
Holding
99
New
5
Increased
24
Reduced
50
Closed
1

Top Sells

Rank Stock Value
1
CLS icon
Celestica
CLS
+$126M
2
VMW
VMware, Inc
VMW
+$44.6M
3
MFC icon
Manulife Financial
MFC
+$4.47M
4
SBS icon
Sabesp
SBS
+$4.36M
5
CX icon
Cemex
CX
+$4.16M

Sector Composition

Rank Sector Weight
1 Financials 29.53%
2 Communication Services 16.63%
3 Energy 11.73%
4 Materials 11.71%
5 Healthcare 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
URTH icon
76
iShares MSCI World ETF
URTH
$8.19B
$889K 0.02%
7,400
ING icon
77
ING
ING
$105B
$886K 0.02%
67,229
-368
-0.5% -$5.18K
MET icon
78
MetLife
MET
$61.7B
$815K 0.02%
12,949
SPY icon
79
State Street SPDR S&P 500 ETF Trust
SPY
$803B
$735K 0.01%
1,720
HDB icon
80
HDFC Bank
HDB
$118B
$584K 0.01%
+19,800
New +$645K
VTWO icon
81
Vanguard Russell 2000 ETF
VTWO
$16.9B
$500K 0.01%
7,000
GOOGL icon
82
Alphabet (Google) Class A
GOOGL
$4.27T
$330K 0.01%
2,520
VT icon
83
Vanguard Total World Stock ETF
VT
$81B
$321K 0.01%
3,450
-6,300
-65% -$612K
DUK icon
84
Duke Energy
DUK
$93.1B
$274K 0.01%
3,100
ENB icon
85
Enbridge
ENB
$104B
$255K 0.01%
7,650
KMB icon
86
Kimberly-Clark
KMB
$33B
$245K ﹤0.01%
2,025
CVE.WS
87
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
$231K ﹤0.01%
15,257
MSFT icon
88
Microsoft
MSFT
$3.75T
$201K ﹤0.01%
638
-10
-2% -$3.3K
OM icon
89
Outset Medical
OM
$60.3M
$147K ﹤0.01%
903
SPRY icon
90
ARS Pharmaceuticals
SPRY
$473M
$136K ﹤0.01%
+36,000
New +$236K
LYRA
91
DELISTED
LYRA THERAPEUTICS INC
LYRA
$125K ﹤0.01%
638
MGTX icon
92
MeiraGTx Holdings
MGTX
$1.23B
$111K ﹤0.01%
+22,700
New +$138K
MLYS icon
93
Mineralys Therapeutics
MLYS
$2.56B
$108K ﹤0.01%
11,400
TCRX icon
94
TScan Therapeutics
TCRX
$21.7M
$82.9K ﹤0.01%
+32,400
New +$75.6K
PROK icon
95
ProKidney
PROK
$376M
$72.8K ﹤0.01%
15,900
CBIO
96
Crescent Biopharma
CBIO
$721M
$67.9K ﹤0.01%
453
MDNA
97
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$35.4K ﹤0.01%
120,000
ATRA icon
98
Atara Biotherapeutics
ATRA
$94.2M
$25.9K ﹤0.01%
700
VMW
99
DELISTED
VMware, Inc
VMW
-310,134
Closed -$44.6M

Similar funds

Letko, Brosseau & Associates's Q3 2023 Portfolio in Review

As of Q3 2023, Letko, Brosseau & Associates held 99 positions worth $5.1B, down 4.9% from $5.37B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Letko, Brosseau & Associates's Q3 2023 filing shows 5 new, 24 increased, 50 reduced and 1 closed positions. Its largest new stake was Fidelity National Information Services: 561,000 shares worth $31M. The largest sale was Celestica, an estimated $126M.

By sector, the portfolio is most concentrated in Financials at 30% of assets, down from 30% a quarter earlier, followed by Communication Services and Energy.

  • Letko, Brosseau & Associates's largest Q3 2023 buy was Fidelity National Information Services: 561,000 shares worth $31M.
  • Letko, Brosseau & Associates added most to CVS Health in Q3 2023, an estimated $18.1M increase.
  • Letko, Brosseau & Associates's biggest Q3 2023 reduction was Celestica, cutting an estimated $126M.
  • Letko, Brosseau & Associates fully exited VMware, Inc in Q3 2023, selling an estimated $44.6M.
  • Letko, Brosseau & Associates's ten largest holdings make up 33% of its $5.1B portfolio in Q3 2023.
  • Letko, Brosseau & Associates opened 5 new positions and closed 1 in Q3 2023.
  • Letko, Brosseau & Associates's portfolio value fell 4.9% quarter-over-quarter to $5.1B.

Based on Letko, Brosseau & Associates's 13F filing for Q3 2023, filed 9 Nov 2023.